Literature DB >> 4957083

Capreomycin in the treatment of pulmonary tuberculosis.

I Donomae.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4957083     DOI： 10.1111/j.1749-6632.1966.tb45543.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  [Clinical experiences with the tuberculostatic drug capreomycin].

Authors:  H Kollmeier; E Winkler; H Voss; M Ilgner
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1968

2.  [Personal experiences with capreomycin].

Authors:  C Virchow
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1967

3.  Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

Authors:  Amber Arnold; Graham S Cooke; Onn Min Kon; Martin Dedicoat; Marc Lipman; Angela Loyse; Irina Chis Ster; Thomas S Harrison
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs.

Authors:  L Garcia-Contreras; Pavan Muttil; John K Fallon; Mohan Kabadi; Robert Gerety; Anthony J Hickey
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

5.  Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model.

Authors:  L Garcia-Contreras; J Fiegel; M J Telko; K Elbert; A Hawi; M Thomas; J VerBerkmoes; W A Germishuizen; P B Fourie; A J Hickey; D Edwards
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

6.  Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model.

Authors:  P Le Conte; F Le Gallou; G Potel; L Struillou; D Baron; H B Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 7.  Ototoxicity of Non-aminoglycoside Antibiotics.

Authors:  Leonard P Rybak; Vickram Ramkumar; Debashree Mukherjea
Journal:  Front Neurol       Date:  2021-03-09       Impact factor: 4.003

8.  Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Authors:  Christoph Lange; Ibrahim Abubakar; Jan-Willem C Alffenaar; Graham Bothamley; Jose A Caminero; Anna Cristina C Carvalho; Kwok-Chiu Chang; Luigi Codecasa; Ana Correia; Valeriu Crudu; Peter Davies; Martin Dedicoat; Francis Drobniewski; Raquel Duarte; Cordula Ehlers; Connie Erkens; Delia Goletti; Gunar Günther; Elmira Ibraim; Beate Kampmann; Liga Kuksa; Wiel de Lange; Frank van Leth; Jan van Lunzen; Alberto Matteelli; Dick Menzies; Ignacio Monedero; Elvira Richter; Sabine Rüsch-Gerdes; Andreas Sandgren; Anna Scardigli; Alena Skrahina; Enrico Tortoli; Grigory Volchenkov; Dirk Wagner; Marieke J van der Werf; Bhanu Williams; Wing-Wai Yew; Jean-Pierre Zellweger; Daniela Maria Cirillo
Journal:  Eur Respir J       Date:  2014-03-23       Impact factor: 16.671

9.  Controlled-release approaches towards the chemotherapy of tuberculosis.

Authors:  Bullo Saifullah; Mohd Zobir B Hussein; Samer Hasan Hussein Al Ali
Journal:  Int J Nanomedicine       Date:  2012-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.